Jacobson Pharma Corp. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG677291067
HKD
1.25
0.02 (1.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jacobson Pharma Corp. Ltd.
JBM (Healthcare) Ltd.

Why is Jacobson Pharma Corp. Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 1.91% and Operating profit at 10.39% over the last 5 years
2
Flat results in Sep 25
  • CASH AND EQV(HY) Lowest at HKD 395.06 MM
  • DEBT-EQUITY RATIO (HY) Highest at 22.81 %
3
With ROE of 13.30%, it has a Fair valuation with a 1.20 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 4.17%, its profits have risen by 50.9% ; the PEG ratio of the company is 0.2
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Jacobson Pharma Corp. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jacobson Pharma Corp. Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Jacobson Pharma Corp. Ltd.
4.17%
2.99
35.13%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.91%
EBIT Growth (5y)
10.39%
EBIT to Interest (avg)
6.33
Debt to EBITDA (avg)
1.52
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.44
Tax Ratio
19.50%
Dividend Payout Ratio
59.41%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.92%
ROE (avg)
9.37%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.20
EV to EBIT
8.60
EV to EBITDA
6.18
EV to Capital Employed
1.18
EV to Sales
2.01
PEG Ratio
0.18
Dividend Yield
11.84%
ROCE (Latest)
13.75%
ROE (Latest)
13.30%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
ROCE(HY)

Highest at 12.97%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DIVIDEND PAYOUT RATIO(Y)

Highest at 59.69%

RAW MATERIAL COST(Y)

Fallen by -4.77% (YoY

-2What is not working for the Company
CASH AND EQV(HY)

Lowest at HKD 395.06 MM

DEBT-EQUITY RATIO (HY)

Highest at 22.81 %

Here's what is working for Jacobson Pharma Corp. Ltd.

Dividend Payout Ratio
Highest at 59.69%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -4.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 76.53 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Jacobson Pharma Corp. Ltd.

Cash and Eqv
Lowest at HKD 395.06 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 22.81 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio